U.S. Attorney charges pharma rep in kickbacks
Compliance Monitor, December 22, 2004
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
The U.S. Attorney in Massachusetts December 15 charged a pharmaceutical sales representative with offering physicians all-expenses paid trips to France in exchange for prescribing his company's AIDS drug.
Adam Stupak, 40, of Hewlit, NY, was named in a filing by the U.S. Department of Justice for his alleged role in Rockland, MA-based Serono, Inc.'s plan to increase sluggish sales of Serostim (approved by the FDA to fight AIDS wasting) that included providing kickbacks to three New York City physicians.
According to the U.S. Attorney, Serostim's six regional sales directors allegedly were instructed by upper management to offer the trips to the third International Conference on Nutrition and HIV Infection held in April 1999 as part of the company's "$6m-6 Day Plan," which set a goal of raising $6 million in six days.
Each trip-induced prescription of Serostim was for a 12-week treatment course valued at approximately $630,000 to Serono. Stupak allegedly offered the trip to the three physicians contingent on them writing at least 10 additional prescriptions of Serostim.
The U.S. Attorney's office said Stupak's push allegedly helped Serono net $6.3 million.
If convicted on three counts of offering to pay illegal remunerations, Stupak would face up to five years in prison followed by three years of supervised release, and a $75,000 fine on each count, according to the U.S. Attorney.
Want to receive articles like this one in your inbox? Subscribe to Compliance Monitor!
Related Products
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Identify potential Medicaid RAC target areas
- HIPAA Q&A: Level of encryption needed for email
- Topic: CMS, OESS post new security compliance review information, checklist
- Capturing all necessary codes for IUD insertion and removal can be challenging
- What does case-mix index mean to you?
- OB services: Coding inside and outside of the package
- QA:Coding multiple initial infusions
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- CMS has reformulated payments for some bilateral procedures
- HIPAA Q&A: Level of encryption needed for email
- Q&A: Follow CMS' coding guidelines when using modifier -25
- What does case-mix index mean to you?
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- Q/A. One injection code or two?
- Cohesive History and Physical Requirements
- Searched
